Trial intelligence / Profile preview

Resistance Training and Calcitriol in Cancer Patients

NCT03469271Phase 4Completed

Sponsor
Mayo Clinic
Start
May 2018
Primary completion
May 2020
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of calcitriol in cancer, sponsored by Mayo Clinic. Started May 2018; status: completed.

02

Drugs

calcitriol
03

Conditions

cancer

Beyond the preview

Go deeper on NCT03469271.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03469271.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call